Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

about

Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue.

P2860

Q36175267-5C7A90B6-941C-48F0-808E-B11C681EE43E

P2860

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

Item

http://www.wikidata.org/entity/Q35807774

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

@ast

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

@en

type

Item

label

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

@ast

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

@en

prefLabel

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

@ast

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

@en

P1476

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

@en

P2093

Masahiko Hoshijima

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility.

beta-adrenergic receptor blockade in chronic heart failure.

In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.

Mixed signals in heart failure: cancer rules.

Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.

Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats.

Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter.

Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies

P304

320-331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1196/ANNALS.1302.028

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1015

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15201171

http://www.w3.org/2001/XMLSchema#string

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

about

P2860

P2860

Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698